Skip to main content
. 2014 Feb 27;4(1):35–49. doi: 10.3390/jpm4010035

Table 3.

Provider baseline measures.

Concept Definition Items 1
Attitudes toward adoption Attitudes toward adoption of genome-guided prescribing CDS Twelve items (Evidence Based Practice Attitude
Scale—Genome Informed Interventions, EBPAS-GII) 2
Perceived usefulness Perceived usefulness of genome-guided prescribing CDS Two items: patient genotype data is useful for making prescribing decisions; decision support aids are useful for making prescribing decisions
Rating scales range from 1 to 5:
1 = definitely false
2 = mostly false
3 = don’t know
4 = mostly true
5 = definitely true
Awareness Awareness of genome-guided prescribing CDS Two items: how aware are you of decision support aids; how aware are you of genome-guided prescribing
Rating scales are binary:
0 = unaware of use
1 = aware of use
Experience Experience with genome-guided prescribing CDS Two items: how often do you use decision
support aids; how often do you perform
genome-guided prescribing
Rating scales range from 0 to 2:
0 = never use
1 = sometimes use
2 = often use
Comfort using technology Comfort using computers and the local electronic health record system Two items: how comfortable are you with using computers; how comfortable are you with using Epic (the local electronic health record system)?
Rating scale ranges from 1 to 5:
1 = not at all comfortable
2 = not very comfortable
3 = neither comfortable or uncomfortable
4 = comfortable
5 = very comfortable
Covariate Socially desirable response (SDR) scale 3

1 Items from baseline questionnaires distributed during the training session. 2 Adapted from the Evidence Based Practice Attitude Scale [17,18] (See Table 1 and Table 2). 3 Socially desirable response scale (SDRS-5) [19].